Andrew Sauer, MD
Advanced Heart Failure and Transplant Cardiology · Lees Summit, MONPI 1356546956
Payments from drug & device makers
Across 777 payments — averaging $4717.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$1.2M
- Bayer$820K
- Edwards Lifesciences$757K
- Amgen$178K
- Novartis$160K
- Vifor (international) Ltd.$156K
- plus $369K from 17 others
Across 3 payments — averaging $1855.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biotronik Inc.$3K
- Medtronic$2K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 273 | $1,226,464 |
| Bayer | 81 | $820,082 |
| Edwards Lifesciences | 65 | $756,504 |
| Amgen | 26 | $177,854 |
| Novartis | 27 | $160,405 |
| Vifor (international) Ltd. | 3 | $155,546 |
| Boehringer Ingelheim | 4 | $70,766 |
| Pfizer | 12 | $69,791 |
| Impulse Dynamics (USA) Inc. | 43 | $55,309 |
| Boston Scientific | 63 | $50,883 |
| AstraZeneca | 13 | $50,558 |
| Cvrx, Inc. | 19 | $44,850 |
| Medtronic(2 entities) | 16 | $12,462 |
| Boehringer Ingelheim International GmbH | 3 | $3,962 |
| Novo Nordisk AS | 113 | $3,366 |
| Roche Diagnostics Corporation | 1 | $2,980 |
| Terumo Medical Corporation | 6 | $2,800 |
| Impedimed, Inc. | 1 | $500 |
| Endotronix, Inc. | 2 | $379 |
| Idorsia Pharmaceuticals US Inc | 1 | $60 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $34 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
How this compares
$3,665,582 in reported general payments places this provider in the 95th percentile of 26 advanced heart failure and transplant cardiology providers in Missouri.
See all advanced heart failure and transplant cardiology providers in Missouri →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other advanced heart failure and transplant cardiology in Lees Summit
- Timothy FendlerLees Summit$190K
- Ahmad TurkLees Summit$502
- Michael NassifKansas City$1.6M
- Gregory EwaldSaint Louis$663K
- Brett SperryKansas City$661K
- Gerard OghlakianSpringfield$489K
- Kory LavineSaint Louis$448K
- Taiyeb KhumriKansas City$345K
- Andrew KaoKansas City$226K
- Justin HartupeeSaint Louis$145K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.